| Basics |
Pulse Biosciences, Inc.
Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.
|
| IPO Date: |
May 18, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Instruments and Equipment |
| Market Cap: |
$899.28M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.48 | 3.70%
|
| Avg Daily Range (30 D): |
$0.28 | 1.89%
|
| Avg Daily Range (90 D): |
$0.37 | 2.30%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.12M |
| Avg Daily Volume (30 D): |
.12M |
| Avg Daily Volume (90 D): |
.14M |
| Trade Size |
| Avg Trade Size (Sh.): |
96 |
| Avg Trade Size (Sh.) (30 D): |
59 |
| Avg Trade Size (Sh.) (90 D): |
62 |
| Institutional Trades |
| Total Inst.Trades: |
100 |
| Avg Inst. Trade: |
$1.62M |
| Avg Inst. Trade (30 D): |
$.66M |
| Avg Inst. Trade (90 D): |
$1.03M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.02M |
| Avg Closing Trade (30 D): |
$.66M |
| Avg Closing Trade (90 D): |
$1.27M |
| Avg Closing Volume: |
153.04K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.14
|
$-.29
|
$-.28
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$ .09M
|
$ .09M
|
$ M
|
|
Gross Profit
|
$
|
$ -.19M
|
$
|
|
Net Income / Loss
|
$ -74.73M
|
$ -19.39M
|
$ -19.17M
|
|
Operating Income / Loss
|
$ -78.95M
|
$ -20.37M
|
$ -20.28M
|
|
Cost of Revenue
|
$
|
$ .28M
|
$
|
|
Net Cash Flow
|
$ 16.18M
|
$ -11.14M
|
$ -12.93M
|
|
PE Ratio
|
|
|
|
|
|
|
